• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺功能亢进合并CYP 24A1基因突变。

Hyperparathyroidism complicating CYP 24A1 mutations.

作者信息

Loyer Camille, Leroy Clara, Molin Arnaud, Odou Marie-Françoise, Huglo Damien, Lion Georges, Ernst Olivier, Hoffmann Maxime, Porchet Nicole, Carnaille Bruno, Pattou François, Kottler Marie-Laure, Vantyghem Marie-Christine

机构信息

Endocrinology and Metabolism Department, C. Huriez Hospital, Lille University Hospital, 1, rue Polonovski, 59037 Lille cedex, France.

Department of Genetics, University Hospital, 14000 Caen, France.

出版信息

Ann Endocrinol (Paris). 2016 Oct;77(5):615-619. doi: 10.1016/j.ando.2016.03.002. Epub 2016 Jul 1.

DOI:10.1016/j.ando.2016.03.002
PMID:27378451
Abstract

CYP24A1 gene mutations induce infantile hypercalcemia, with high 1,25(OH)D contrasting with low PTH levels. The adult phenotype is not well known. Two unrelated adult patients were referred for nephrolithiasis, hypertension, hypercalcemia, hypercalciuria, normal 25-OHD levels, and inappropriate PTH levels (22 to 92pg/mL;N: 15-68) suggesting primary hyperparathyroidism, leading to surgery. Hypercalciuria improved despite persistent hypercalcemia, treated with cinacalcet. The ratio 25-OHD/24-25-(OH)2D>100 (N<25) suggested the diagnosis of CYP24A1 mutations which were confirmed through Sanger sequencing. In conclusion, the adult phenotype associated with CYP24A1 mutations can evolve over time from hypercalcemia with suppressed PTH towards hyperparathyroidism with moderately increased PTH level, adenoma and/or slightly increased parathyroid glands. Surgery decreased calciuria and improved kidney function. Cinacalcet was partially effective on hypercalcemia since PTH was inappropriate. This novel phenotype, a phenocopy of hyperparathyroidism, might evolve in few cases towards hyperparathyroidism despite random association of the 2 diseases cannot be excluded.

摘要

CYP24A1基因突变可导致婴儿高钙血症,其1,25(OH)D水平升高,而甲状旁腺激素(PTH)水平降低。成人的表型尚不清楚。两名无亲缘关系的成年患者因肾结石、高血压、高钙血症、高钙尿症、25-OHD水平正常以及PTH水平异常(22至92pg/mL;正常范围:15 - 68)而就诊,提示原发性甲状旁腺功能亢进,随后接受了手术治疗。尽管高钙血症持续存在,但使用西那卡塞治疗后高钙尿症有所改善。25-OHD/24 - 25-(OH)2D比值>100(正常范围<25)提示CYP24A1基因突变,通过桑格测序得以证实。总之,与CYP24A1基因突变相关的成人表型可能会随时间从PTH受抑制的高钙血症演变为PTH水平中度升高、伴有腺瘤和/或甲状旁腺轻度增大的甲状旁腺功能亢进。手术降低了尿钙水平并改善了肾功能。由于PTH水平异常,西那卡塞对高钙血症仅部分有效。这种新的表型,即甲状旁腺功能亢进的拟表型,在少数情况下可能会演变为甲状旁腺功能亢进,尽管不能排除这两种疾病的偶然关联。

相似文献

1
Hyperparathyroidism complicating CYP 24A1 mutations.甲状旁腺功能亢进合并CYP 24A1基因突变。
Ann Endocrinol (Paris). 2016 Oct;77(5):615-619. doi: 10.1016/j.ando.2016.03.002. Epub 2016 Jul 1.
2
Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.因 CYP24A1 突变导致维生素 D 24-羟化作用受损的患者的肾功能和阳光暴露的影响。
Am J Kidney Dis. 2015 Jan;65(1):122-6. doi: 10.1053/j.ajkd.2014.06.037. Epub 2014 Nov 4.
3
CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.CYP24A1功能丧失:单等位基因和双等位基因突变的临床表型。
J Steroid Biochem Mol Biol. 2017 Oct;173:337-340. doi: 10.1016/j.jsbmb.2017.01.006. Epub 2017 Jan 16.
4
Persistent hypercalcaemia associated with two pathogenic variants in the gene and a parathyroid adenoma-a case report and review.与基因中的两个致病性变异体和甲状旁腺腺瘤相关的持续性高钙血症:病例报告及文献复习。
Front Endocrinol (Lausanne). 2024 Apr 11;15:1355916. doi: 10.3389/fendo.2024.1355916. eCollection 2024.
5
Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.CYP24A1 基因(维生素 D24-羟化酶基因)的功能丧失性突变可导致长期存在的高钙尿性肾结石和肾钙质沉着症。
J Urol. 2013 Aug;190(2):552-7. doi: 10.1016/j.juro.2013.02.3188. Epub 2013 Mar 5.
6
CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.CYP24A1 基因突变在高钙血症患者队列中的研究:隐性特征的证据。
J Clin Endocrinol Metab. 2015 Oct;100(10):E1343-52. doi: 10.1210/jc.2014-4387. Epub 2015 Jul 27.
7
Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect.单等位基因和双等位基因CYP24A1突变的成年人的临床和生化表型:基因剂量效应的证据。
Osteoporos Int. 2016 Oct;27(10):3121-5. doi: 10.1007/s00198-016-3615-6. Epub 2016 Apr 29.
8
Therapy-Resistant Hypercalcemia in a Patient with Inactivating CYP24A1 Mutation and Recurrent Nephrolithiasis: Beware of Concomitant Hyperparathyroidism.伴有 CYP24A1 失活突变和复发性肾结石的治疗抵抗性高钙血症患者:警惕同时存在的甲状旁腺功能亢进症。
Calcif Tissue Int. 2020 Nov;107(5):524-528. doi: 10.1007/s00223-020-00738-8. Epub 2020 Aug 2.
9
Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia.一组意大利特发性婴儿高钙血症患者中CYP24A1基因的突变谱
Nephron. 2016;133(3):193-204. doi: 10.1159/000446663. Epub 2016 Jul 9.
10
Analysis of vitamin D metabolites in survivors of infantile idiopathic hypercalcemia caused by CYP24A1 mutation or SLC34A1 mutation.分析 CYP24A1 突变或 SLC34A1 突变所致婴儿特发性高钙血症幸存者的维生素 D 代谢产物。
J Steroid Biochem Mol Biol. 2021 Apr;208:105824. doi: 10.1016/j.jsbmb.2021.105824. Epub 2021 Jan 28.

引用本文的文献

1
Persistent Hypercalcemia Despite Parathyroidectomy for Primary Hyperparathyroidism in an Adult with Nephrocalcinosis and Nephrolithiasis Caused by a Novel Combination of Two Pathogenic Mutations.一名患有肾钙质沉着症和肾结石的成年人因原发性甲状旁腺功能亢进接受甲状旁腺切除术后仍持续高钙血症,病因是两种致病突变的新组合。
Int J Mol Sci. 2025 Sep 15;26(18):8965. doi: 10.3390/ijms26188965.
2
Persistent hypercalcaemia associated with two pathogenic variants in the gene and a parathyroid adenoma-a case report and review.与基因中的两个致病性变异体和甲状旁腺腺瘤相关的持续性高钙血症:病例报告及文献复习。
Front Endocrinol (Lausanne). 2024 Apr 11;15:1355916. doi: 10.3389/fendo.2024.1355916. eCollection 2024.
3
Hypervitaminosis D Secondary to a Loss-of-Function Mutation: An Unusual Cause of Hypercalcemia in Two Siblings.
功能丧失性突变继发维生素D过多症:两例同胞高钙血症的罕见病因
JBMR Plus. 2023 Aug 8;7(9):e10788. doi: 10.1002/jbm4.10788. eCollection 2023 Sep.
4
Diseases associated with calcium-sensing receptor.与钙敏感受体相关的疾病。
Orphanet J Rare Dis. 2017 Jan 25;12(1):19. doi: 10.1186/s13023-017-0570-z.